Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/123607
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia
Author: Thomson, D.W.
Shahrin, N.H.
Wang, P.P.S.
Wadham, C.
Shanmuganathan, N.
Scott, H.S.
Dinger, M.E.
Hughes, T.P.
Schreiber, A.W.
Branford, S.
Citation: Leukemia, 2020; 34(8):2051-2063
Publisher: Springer Nature
Issue Date: 2020
ISSN: 0887-6924
1476-5551
Statement of
Responsibility: 
Daniel W. Thomson, Nur Hezrin Shahrin, Paul P. S. Wang, Carol Wadham, Naranie Shanmuganathan, Hamish S. Scott, Marcel E. Dinger, Timothy P. Hughes, Andreas W. Schreiber, Susan Branford
Abstract: Blast crisis of chronic myeloid leukemia is associated with poor survival and the accumulation of genomic lesions. Using whole-exome and/or RNA sequencing of patients at chronic phase (CP, n = 49), myeloid blast crisis (MBC, n = 19), and lymphoid blast crisis (LBC, n = 20), we found 25 focal gene deletions and 14 fusions in 24 patients in BC. Deletions predominated in LBC (83% of structural variants). Transcriptional analysis identified the upregulation of genes involved in V(D)J recombination, including RAG1/2 and DNTT in LBC. RAG recombination is a reported mediator of IKZF1 deletion. We investigated the extent of RAG-mediated genomic lesions in BC. Molecular hallmarks of RAG activity; DNTT-mediated nucleotide insertions and a RAG-binding motif at structural variants were exclusively found in patients with high RAG expression. Structural variants in 65% of patients in LBC displayed these hallmarks compared with only 5% in MBC. RAG-mediated events included focal deletion and novel fusion of genes associated with hematologic cancer: IKZF1, RUNX1, CDKN2A/B, and RB1. Importantly, 8/8 patients with elevated DNTT at CP diagnosis progressed to LBC by 12 months, potentially enabling early prediction of LBC. This work confirms the central mutagenic role of RAG in LBC and describes potential clinical utility in CML management.
Keywords: Humans
Blast Crisis
DNA Nucleotidylexotransferase
DNA-Binding Proteins
Homeodomain Proteins
Nuclear Proteins
Computational Biology
Gene Deletion
Recombination, Genetic
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Description: Published: 19 February 2020
Rights: © The Author(s), under exclusive licence to Springer Nature Limited 2020
DOI: 10.1038/s41375-020-0751-y
Grant ID: http://purl.org/au-research/grants/nhmrc/1135949
http://purl.org/au-research/grants/nhmrc/1027531
http://purl.org/au-research/grants/nhmrc/1104425
http://purl.org/au-research/grants/nhmrc/1117718
Published version: http://dx.doi.org/10.1038/s41375-020-0751-y
Appears in Collections:Aurora harvest 8
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.